Acasti Pharma Inc
XTSX:ACST
Acasti Pharma Inc
XTSX:ACST
Price:
0.58
CAD
1.75%
Market Cap:
CA$25.9m
Income Statement
Earnings Waterfall
Acasti Pharma Inc
Acasti Pharma Inc
Income Statement
Acasti Pharma Inc
Acasti Pharma Inc
Currency: USD
| Mar-2021 | Mar-2022 | Mar-2023 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||
| Cost of Revenue |
(0)
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||
| Operating Expenses |
(11)
|
(15)
|
(18)
|
|
| Selling, General & Administrative |
(7)
|
(10)
|
(8)
|
|
| Research & Development |
(2)
|
(2)
|
(2)
|
|
| Depreciation & Amortization |
(1)
|
0
|
(0)
|
|
| Other Operating Expenses |
(1)
|
(3)
|
(8)
|
|
| Operating Income |
(11)
N/A
|
(15)
-43%
|
(18)
-19%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(3)
|
5
|
0
|
|
| Non-Reccuring Items |
(6)
|
(0)
|
(34)
|
|
| Total Other Income |
(0)
|
0
|
0
|
|
| Pre-Tax Income |
(20)
N/A
|
(10)
+47%
|
(52)
-397%
|
|
| Net Income | ||||
| Tax Provision |
0
|
1
|
10
|
|
| Income from Continuing Operations |
(20)
|
(10)
|
(42)
|
|
| Net Income (Common) |
(20)
N/A
|
(10)
+50%
|
(42)
-332%
|
|
| EPS (Diluted) |
-7.96
N/A
|
-1.6
+80%
|
-5.71
-257%
|
|
Switch to:
Switch to:
See Also
Discover More
